Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.90% | $17.21M | €328.62B | 37.82% | 76 Outperform | |
| AstraZeneca | 1.40% | $12.68M | £218.59B | 33.88% | 76 Outperform | |
| Roche Holding AG | 1.37% | $12.42M | CHF250.94B | 38.47% | 73 Outperform | |
| Nestlé SA | 1.28% | $11.59M | CHF202.01B | 15.24% | 71 Outperform | |
| Novartis AG | 1.24% | $11.20M | CHF199.04B | 12.04% | 80 Outperform | |
| SAP SE | 1.22% | $11.04M | €239.08B | -8.13% | 66 Neutral | |
| HSBC Holdings | 1.20% | $10.88M | £180.44B | 43.54% | 79 Outperform | |
| Shell (UK) | 1.06% | $9.63M | £158.51B | 8.98% | 77 Outperform | |
| Toyota Motor | 1.05% | $9.46M | ¥40.10T | 16.34% | 81 Outperform | |
| Siemens | 0.98% | $8.85M | €177.78B | 24.82% | 74 Outperform |